Diseases, Conditions, Syndromes

RSV: We finally have a vaccine for this deadly virus

The first vaccine against respiratory syncytial virus (RSV) has been approved by the US Food and Drug Administration. The vaccine, named Arexvy, will be given to people 60 years and older.

Immunology

How the microbiome affects the immune system

The building blocks of life-long health are the subject of a cutting-edge review examining how a newborn's lung microbiome affects the immune system for years to come.

page 10 from 40